StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Prakash Gaba

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

byPrakash GabaHorizon: BTST24 Aug 2026, 3:14 pm ISTvia CNBC Awaaz.

Entry₹1,190Inferred
Target₹1,200
Total upside +0.84% (call closed)
Stop loss₹1,185-0.42% risk
Exit₹1,18525 Aug 2026, 9:16 am
Stop-loss hit-0.42%
Follow Prakash Gaba for new calls(20% target hit, 382 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alertsSee 3 active BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 25 Aug 2026
1 supporting2 neutral1 opposing
Supports the BUY call (1)

1 other SEBI-registered advisor has an active BTST BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·25 Aug · today

Neutral / worth noting (2)

USFDA Closes Dr Reddy's UK API Plant Inspection With VAI Classification

NewsGoogle News·19 Aug · 5d ago

(opens in new tab)

FDA closes Dr. Reddy’s (NYSE: RDY) UK plant inspection

NewsGoogle News·17 Aug · 1w ago

(opens in new tab)
Weighs against the BUY call (1)

FDA flags four issues at Dr. Reddy’s (NYSE: RDY) Hyderabad plant after August inspection

NewsGoogle News·17 Aug · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Prakash Gaba

Every call and its outcome